A recent National Academies of Sciences, Engineering, and Medicine report details several adverse impacts from poor diversity in clinical trials. These include lack of access to effective medical interventions, compounding of health disparities in underrepresented and excluded populations, and hindering innovation. Read the Full Article.
Home / Community / Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
Recent Posts
- Scientists Sleuth Out the Mysteries of Dynamic Protein Droplets Formed Within Cells.
- AI-Powered Exoskeleton Enhances Human Locomotion, Helps Restores Mobility.
- Rutgers Researchers Identify Impacts of Russia-Ukraine War on Hospitals.
- Majority of New Jerseyans Worried About Medical and Health Care Costs.
- NJACTS Community Engagement Core COVID-19 Resources
Categories
- Community (1,937)
- Covid (970)
- CTO Events (1)
- News (2,480)
- Pilots (20)